CVM Projected Dividend Yield
Com Par $0.01 (New)/CEL-SCI Corporation ( AMEX : CVM )CEL-SCI is a clinical-stage biotechnology company engaged in the research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine, which is an investigational immunotherapy under development for the treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology with a product candidate, CEL-4000, which is under development for the treatment of rheumatoid arthritis. 21 YEAR PERFORMANCE RESULTS |
CVM Dividend History Detail CVM Dividend News CVM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |